R-Luc mRNA has been designed to produce high expression level of Renilla Luciferase protein. R-Luc mRNAs can be used as control of transfection efficiency as a reporter gene. OZ Biosciences mRNAs are produced by in vitro transcription and stabilised at the 5' end by modified nucleotides capping (Cap1). These mature mRNAs contain a poly(A) tail at the 3' end and are also optimised to yield improved stability and performance.

• Ready-to-use stabilised R-Luc mRNA
• Concentration: 1.0mg/mL in 1mM sodium citrate, pH 6.4
• MRNA20 does not bear any additional nucleotide modifications
• MRNA21 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses
• MRNA7 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response